Log in  First Connection?

Prostate Cancer & BPHArchives

Hyaluronan stimulates transformation of androgen-independent prostate cancer

 Published on 20/03/2026 |  Original article (Full-text)  | Shi-Lung Lin et al. | Carcinogenesis. Volume 28(2).

Interaction between extracellular matrices and cancer cell receptors frequently alters signal transduction pathways, leading to malignant transformation and metastasis. Hyaluronan (HA) is a tumor promoter and enhancer in transformation of androgen-independent (AI) prostate cancer (CaP); however, the...

Impact of positive surgical margin location on biochemical recurrence in pT3 prostate cancer after robot-assisted radical prostatectomy: a retrospective cohort study

 Published on 13/03/2026 |  Original article (Full-text)  | Altay Mehmet Sefa et al. | BMC Urology 2026; 26(1): 56

Prostate cancer (PCa) is the most common solid organ malignancy among men in developed countries and represents one of the leading causes of cancer-related mortality worldwide [1, 2]. Radical prostatectomy (RP) remains the standard surgical treatment for localized and locally advanced PCa [1]. In recent...

C21orf2 as a potential regulator of JAK2/STAT3 signaling in prostate cancer cell proliferation and apoptosis: an exploratory study

 Published on 06/03/2026 |  Original article (Full-text)  | Jiang ShiHao et al. | BMC Cancer 2026; 26(1): 305

Prostate cancer (PCa) is one of the most common malignancies in men worldwide and poses a significant threat to male health [1]. According to the World Health Organization, PCa ranks second in the incidence of newly diagnosed cancers among men globally [2]. In Asia, particularly in China, although the...

Prognostic features of biochemical recurrence of prostate cancer following radical prostatectomy based on diffusion kurtosis imaging

 Published on 27/02/2026 |  Original article (Full-text)  | Lin Li-Peng et al. | Cancer imaging 2026; 26(1): 30

Prostate cancer (PCa) is among the most common malignancies in men. With the widespread adoption of prostate-specific antigen (PSA) screening, detection rates have steadily increased [1]. Radical prostatectomy (RP) remains a first-line treatment for patients with localized or locally advanced disease;...

Suicide risk in prostate cancer patients: epidemiological trends and a predictive modeling

 Published on 20/02/2026 |  Original article (Full-text)  | Yang Yu-Xuan et al. | BMC Psychiatry 2026; 26(1): 163

Prostate cancer is the second most prevalent malignancy globally and the fifth leading cause of cancer-related mortality in males [1].Researchers have extensively investigated factors influencing cancer mortality to develop more effective intervention strategies. A substantial proportion of PCa patients...